In its biggest leveraged buyout (LBO) since 2009, Blackstone Capital Partners VI L.P., has entered into a definitive merger agreement with Paul, Weiss client Emdeon, a publicly traded medical billing provider, for approximately $3 billion. Blackstone will acquire a controlling interest in Emdeon, taking the company private.The transaction was noted today in The New York Times “Dealbook.”
The Paul, Weiss team advising Emdeon includes M&A partners Matthew W. Abbott, Jeffrey D. Marell and Robert B. Schumer, and counsel Da-Wai Hu; finance partners John C. Kennedy and Dale M. Sarro; tax partner Richard J. Bronstein; intellectual property counsel Claudine Meredith-Goujon; litigation partners Allan J. Arffa, Andrew G. Gordon, Stephen P. Lamb and Walter G. Ricciardi; environmental counsel William J. O’Brien; and employee benefits partner Robert C. Fleder and counsel Maureen A. Riley. Partner Joseph J. Simons and counsel Didier Malaquin handled the regulatory aspects of the transaction.
